Literature DB >> 19020991

Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis.

Lian-Hong Li1, Wen-Xian Li, Ou Wu, Guo-Qing Zhang, Hai-Feng Pan, Xiang-Pei Li, Jian-Hua Xu, Hong Dai, Dong-Qing Ye.   

Abstract

Systemic lupus erythematosus (SLE) is a common autoimmune disease with complex etiology. Recently, a possible role of apoptotic cells in its pathogenesis has been suggested. This study is to evaluate the expression of Fas antigen on peripheral blood lymphocytes (PBLs) in SLE, to determine whether membrane Fas (mFas) has a role in the organ damage in SLE and to explore its relationship with the early apoptosis of the PBLs in SLE. Flow cytometry was used to evaluate the expression of mFas on PBLs in 68 Chinese SLE patients and 37 healthy controls. Systemic lupus international collaborative clinics/american colleges of rheumatology damage index (SDI) scores were calculated to further estimate the relationship of the expression of mFas with disease severity. Results showed that mFas expression levels were significantly higher (P < 0.01) among SLE patients than those in healthy controls. Higher (P = 0.01) expressions of mFas were found in patients with SDI scores >or= as compared to those with SDI scores <3. Patients with neuropsychiatric or renal disease had a higher expression of mFas than those without neuropsychiatric (P = 0.03) or renal disease (P = 0.01). In addition, the expression levels had a positive (r = 0.381, P < 0.01) correlation with the early apoptosis rate of PBLs in SLE patients. Taken together, our study showed that Fas-expressing PBLs were increased in SLE patients, especially in patients with higher SDI score, and the expression levels of mFas were correlated to the organ damage and lymphocytes apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020991     DOI: 10.1007/s11033-008-9415-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

Review 1.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Authors:  Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 2.  Apoptosis and systemic lupus erythematosus.

Authors:  Ahmed Sheriff; Udo S Gaipl; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Rheum Dis Clin North Am       Date:  2004-08       Impact factor: 2.670

Review 3.  Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.

Authors:  M Nose; M Nishihara; J Kamogawa; M Terada; S Nakatsuru
Journal:  Rev Immunogenet       Date:  2000

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).

Authors:  M Bijl; G Horst; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 6.  Fas receptor-mediated apoptosis: a clinical application?

Authors:  Tineke Timmer; Elisabeth G E de Vries; Steven de Jong
Journal:  J Pathol       Date:  2002-02       Impact factor: 7.996

Review 7.  Role of apoptosis in autoimmunity.

Authors:  H M Lorenz; M Herrmann; T Winkler; U Gaipl; J R Kalden
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

8.  Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

Authors:  F Silvestris; D Grinello; M Tucci; P Cafforio; F Dammacco
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  Accrual of organ damage over time in patients with systemic lupus erythematosus.

Authors:  Dafna D Gladman; Murray B Urowitz; Proton Rahman; Dominique Ibañez; Lai-Shan Tam
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

10.  Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations.

Authors:  Lucienir M Silva; Aglair B Garcia; Eduardo A Donadi
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

View more
  4 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.

Authors:  Nan Xiang; Xiao-Mei Li; Guo-Sheng Wang; Jin-Hui Tao; Xiang-Pei Li
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

3.  Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.

Authors:  Li-jun Song; Xiao Wang; Xu-ping Wang; Dong Li; Feng Ding; Hua-xiang Liu; Xiao Yu; Xing-fu Li; Qiang Shu
Journal:  Diagn Pathol       Date:  2015-06-16       Impact factor: 2.644

4.  Association of Fas -1377 G/A polymorphism with susceptibility to cancer.

Authors:  Peiliang Geng; Jianjun Li; Juanjuan Ou; Ganfeng Xie; Ning Wang; Lisha Xiang; Rina Sa; Chen Liu; Hongtao Li; Houjie Liang
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.